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A multimedia program (MMP) was developed to educate patients with prostate cancer about their disease. A within-subjects design
was used to investigate the changes in levels of cancer-related knowledge, psychosocial functioning, treatment decision-making role
and information needs immediately after browsing the MMP. The participants were 67 men recently diagnosed with prostate cancer.
Psychosocial functioning was assessed with 20 items describing common emotional states and coping strategies employed by cancer
patients. Treatment decision-making role was assessed with the Control Preference Scale. A principle component analysis of the 20
psychosocial items yielded three components: distress, positive approach and nonacceptance. After browsing the MMP significant
increases in knowledge and reductions in distress were reported. Marital status was significantly associated with knowledge gain.
Married men and those attending the study session with their spouse displayed a significant shift towards a more active role in
treatment decisions. The majority of information needs were fulfilled by the MMP; however, information related to the likelihood of a
cure, treatment side effects, coping strategies and aetiology were not completely satisfied by the MMP. Implications of the findings and
suggestions for future work on the design and evaluation of the MMP are discussed.
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In the UK, one in 14 men are at a lifetime risk of developing
prostate cancer, which is the second leading cause of death in men
after lung cancer, accounting for 9280 deaths in 2000 (Cancer
Research UK, 2002a,b). Treatments for prostate cancer include
surgery, hormone therapy, radiotherapy, chemotherapy and active
monitoring (or watchful waiting). Treatment side effects are
numerous and can occur for short periods, whereas others such as
incontinence and impotence have long-term effects that impact
negatively upon quality of life. However, the probability of
experiencing side effects associated with particular treatments is
unclear from the literature, with large differences in frequency,
duration and severity between studies. Furthermore, the relative
survival benefit of different treatments has yet to be elucidated;
consequently, there is still no unequivocal evidence to support one
treatment over another (Holmberg et al, 2002).
Psychosocial functioning
Psychosocial problems experienced by men with cancer have
received sparse attention compared to women in the research
literature. This difference in attention is hard to justify as research
has shown that men with prostate cancer experience psychosocial
problems such as social role changes, financial worries, anger,
depression and anxiety regarding treatment and potential death
(Gregoire et al, 1997; Gray et al, 1999). Research has also reported
that men with cancer rarely seek help for psychosocial problems
(Jorm, 1994); have little awareness of coping strategies (Whitrod,
1996); are often denied information on positive coping by
clinicians (Fitch et al, 1999); and are prone to relying upon
avoidance-coping strategies associated with poor psychological
outcomes and decreased survival rates (Shrock et al, 1999).
Furthermore, men appear to receive little emotional support other
than from their spouse (Helgason et al, 2001) who also experience
psychosocial problems in response to their partner’s diagnosis
(Gray et al, 1999).
Patient education
Patient education (information provision) has been proven to be
an effective strategy for alleviating psychosocial problems in both
men and women with cancer (Fallowfield et al, 1997; Davison et al,
2003). Information provides a sense of control, reduces distress,
facilitates adaptive coping, and increases participation in shared
decision-making (SDM) with physicians (Gregoire et al, 1997; van
Wersch et al, 1997a,b; Davison et al, 2003). Effective information
provision should enrich doctor–patient interactions by transform-
ing consultations into negotiations between expert patients and
expert physicians; however, in reality it is clinicians, not patients,
who are in possession of the knowledge required to make an
informed decision (Crawford et al, 1997). Despite the general
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lagreement that men should be involved in treatment decisions, the
type and amount of information needed for SDM has failed to
reach a consensus (Feldman-Stewart et al, 1998). Davison et al
(1995) reported the following hierarchical structure of information
needs of men recently diagnosed with prostate cancer: likelihood
of cure, stage of disease, available treatments, side effects on usual
social activity, self-care, treatment side effects, hereditary risks,
effects upon family and friends, and treatment effects upon sexual
activity. Verbal consultations may fulfil these information needs
but this information is subject to poor recall and understanding by
patients (Michie et al, 1997). Consequently, patients are increas-
ingly given printed information to reinforce, or in many cases to
replace, verbal information provided by clinicians (Frank-Strom-
borg and Cohen, 1991). Currently, a combination of information
provision (verbal and printed) with support from healthcare
professionals is considered ‘good clinical practice’. This enables
the healthcare professional to respond according to an individual
patient’s information needs.
The main disadvantages of printed information (and other
media such as audio and videotapes) are that reading level is often
inappropriate; these media possess limited information for
patients who wish to pursue a deeper understanding; they are
unable to adapt quickly to new information; salient topics are often
missing; uncertainties are ignored; and they fail to provide a
balanced account of the effectiveness of available treatments
(Smith and Timoney, 1997; Coulter et al, 1999).
Multimedia patient education
A multimedia program (MMP) is a computer-based application
that combines text, sound, graphics, video and interactivity, which
serve to reinforce and complement one another to facilitate
learning. Multimedia programs presently offer the most compre-
hensive method of information provision that address several of
the shortcomings associated with other media such as printed
information. Multimedia programs can be easily and quickly
updated to incorporate new treatment approaches and evidence
from clinical trails that may refute previous information. Inter-
activity can provide autonomy as it enables patients to dictate the
pace, type and the order information is viewed in the MMP, which
enables more knowledgeable patients to access salient information
more quickly without attending to previously accessed informa-
tion. Multimedia programs provide all the benefits of patient
education without increasing staff costs or time, and are capable of
being accessed at home via the Internet or CD-ROM. Disadvan-
tages of MMPs are initial development and start-up costs and
technology acceptance by clinicians and patients.
Clinical trials of MMPs as health education tools have reported
positive results for increasing patients’ knowledge, information-
seeking and participation in SDM (Krishna et al, 1997). Multi-
media programs for patients with benign prostatic hyperplasia
have reported positive results for reducing self-assessed prostate
symptoms (van Schaik et al, 1999) and facilitating SDM (Barry
et al, 1995; Shepperd et al, 1995; Wagner et al, 1995; Murray et al,
2001). Pilot studies of MMPs for prostate cancer have reported
patient satisfaction with navigability, layout and content (Jenkin-
son et al, 1998; Brink et al, 2000). Patient outcomes such as
participation in SDM were neglected, although Brink et al (2000)
reported increased knowledge of cancer staging and brachytherapy
(the only treatment that was included in the MMP) including
increased patient self-efficacy for discussing brachytherapy with
physicians. These studies demonstrated that MMPs can be effective
media for increasing knowledge of the entire spectrum of
treatment options for prostate cancer.
Therefore, the objective of the current study was to conduct a
‘formative evaluation’ by investigating the effect of the MMP on
knowledge acquisition, psychosocial functioning, preference for
participating in treatment decisions and information needs of
patients recently diagnosed with prostate cancer. A formative
evaluation is an evaluation that takes place before actual
implementation of a final product, and which influences the
development of the product (Preece et al, 1994). The results of the
formative evaluation will be used to conduct a future ‘summative
evaluation’ (undertaken after implementation of the final product,
with the aim of testing the functioning of a product) of the final
version of the MMP. Involving patients in the formative evaluation
is in line with guidelines for conducting research affecting patients
in the UK (DoH, 2001).
MATERIALS AND METHODS
Design
A within-subjects design was used to evaluate the utility of the
MMP. The independent variables were study condition (pretrial –
immediately before using the MMP and post-trial – immediately
after using the MMP), patient age, education, living circumstances
and employment status. The outcome measures were the level of
cancer-related knowledge, psychosocial functioning, treatment
decision-making role and information needs.
Participants
The participants were 67 men recently diagnosed (1 week or less)
with prostate cancer. The men were selected based on consultant
urologists’ assessment of their suitability for inclusion in the study.
The age range was 48–89 with a mean age of 65.7 years
(SD¼7.95). The percentage of participants with secondary
(school, aged p16), further (college, aged X16) and higher
education (university, ages X18) was 50, 36 and 14% respectively.
The majority were married (90%), retired (76%), resided in their
own homes with at least one other person (84%) and attended the
study session with their spouse (70%).
Multimedia program
An MMP was developed using previous research on the informa-
tion needs of prostate cancer patients (e.g. Davison et al, 1995) and
a working committee consisting of two consultant urologists, a
health psychologist, a psychologist specialising in human–
computer interaction and a multimedia developer. The MMP
combined text with sound, narration, images, animation and
streaming video. The MMP was comprised of six cancer-related
modules: (a) prostate anatomy, (b) disease stages, aetiology and
symptoms, (c) diagnostic techniques, (d) treatment options
(surgery, hormone therapy and radiotherapy) and side effects,
which included a research update, (e) coping strategies and (f)
further information (self-help groups, prostate cancer organisa-
tions, further reading and a cancer glossary). The MMP was
operated on a stand-alone PC and participants navigated through
the MMP using a mouse. The interface used a selection of on-
screen buttons (forward, back, exit) that controlled interaction and
navigation through the MMP. Participants were instructed how to
use the MMP by a research assistant who was present throughout
the study session.
Study questionnaire
A questionnaire in hard-copy format was used to assess
psychosocial functioning, cancer-related knowledge, treatment
decision-making roles and information needs. The first part of
the questionnaire described the aims and objectives of the research
and requested demographical information from the participants.
Cancer-related knowledge was assessed using 20 statements that
were representative of the information presented in the six cancer-
related modules of the MMP: cancer in general and prostate
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surgery, radiotherapy and hormone therapy (see Table 1).
Participants responded to each statement as ‘true’, ‘false’ or ‘don’t
know’.
Previous research on emotional states and coping strategies
employed by cancer patients was used to design a 20-item checklist
to assess psychosocial functioning. Six items used adjectives as
descriptors for internal emotional states (e.g. angry); the remain-
ing 14 items used brief statements related to coping strategies for
dealing with cancer (see Table 2). The participants responded to
each item on a three-point Likert scale (not at all, a little and very
much).
The Control Preference Scale developed by Degner and Sloan
(1992) was used to assess the treatment decision-making role,
which has been used previously to assess treatment decision-
making preferences of prostate cancer patients (e.g. Davison et al,
1995). Participants indicated their preferred role in treatment
decision-making (active, passive or collaborative) by selecting the
category indicative of their status.
Information needs were assessed with free-response items
that asked participants to state their most important information
need at pre- and post-trial. Participants were also asked to
state the most important knowledge they had acquired at
post-trial.
Procedure
Ethical approval for the study was granted by the Trust on the
basis that it was part of existing practice to provide practical
advice, guidance and support to men with newly diagnosed with
prostate cancer. After the ‘bad news’ consultation the urologist or
prostate cancer nurse informed the participant about the study and
provided them with a study information sheet (that detailed the
study aims and rationale) and a consent form. Participants were
given the choice of participating immediately, or within 1 week
after the initial bad news consultation. They were also given the
choice of attending the study session with a significant other or
alone. A private room situated within the urology department was
used to conduct the study. Prior to browsing the MMP, the
participants were asked to complete the study questionnaire,
Table 1 The 20 statements used to assess cancer-related knowledge
Knowledge
Pretrial Post-trial
Cancer in general and prostate anatomy 2.49
a (1.01)
b 2.82 (0.75)
Male hormones are produced by the brain
Cancer is a type of infection of tissue
The prostate is part of the penis
The prostate surrounds the first part of the tube
which carries urine from the bladder to the penis
Disease advancement 2.75 (1.29) 3.13 (1.08)
Cancer is a lump of cells that may invade and
destroy surrounding tissues
Prostate cancer can spread to other parts of the
body
Prostate cancer never spreads outside the prostate
Growth of prostate cancer is driven by the male
hormones
Aims and side effects of surgery 3.07 (0.98) 3.22 (0.94)
The aim of prostate surgery is to remove part or all
of the tumour in the prostate
The aim of prostate surgery is to remove the
testicles
Possible side effects of prostate surgery include
problems in control of the bladder
After prostate surgery most prostate patients are
incontinent
Aims and side effects of radiotherapy 2.39 (1.05) 2.67 (0.68)
A possible side effect of radiotherapy is breast
enlargement
Possible side ffects of radiotherapy include tiredness
and nausea
The aim of radiotherapy is to destroy cancer cells
while doing as little harm as possible to normal cells
The aim of radiotherapy is to remove the prostate
Aims and side effects of hormone therapy 1.92 (1.27) 2.55 (1.00)
The aim of hormone therapy is to increase the
amount of male hormones
Possible side effects of hormone therapy include
the inability to have an erection
The aim of hormone therapy is to slow down or
shrink the tumour
A possible side effect of hormone therapy is
increased body strength
Overall 12.62 (3.90) 14.38
(3.00)
aMean.
bs.d.
Table 2 Percentage and cumulative percentage of variance explained
per component, and component loading matrix from the principle
components factor analysis of the psychosocial functioning items
Component
Item Distress
Positive
approach Nonacceptance
Shocked 0.77
I cannot believe this has
happened to me
0.53
I expected it
Angry
Anxious 0.92
Frightened 0.79
Uncertain
Blame myself 0.84
Miserable
Having a good cry
Running away 0.94
Pray to God
Talk to other patient
Talking to someone I trust 0.52
I feel like going to another
doctor to make sure it is true
0.74
Finding out more on prostate
cancer
Do not think about it
Carry on with your life 0.75
Fight this disease 0.74
Enjoy myself as much as I can 0.86
% age of variance explained 24.7 12.6 9.7
Cumulative % 24.7 37.3 47.0
Extraction method: principle components analysis. Rotation method: direct Oblimin
with Kaiser normalisation. The stem question preceding the 20 psychosocial
functioning items was ‘please tick one box for each of the following statements to
indicate how you feel now about your prostate cancer’ (very much, a little or not at
all).
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time limit was imposed on patients for browsing the MMP.
After browsing the MMP, participants were requested to
complete the study questionnaire for a second time. They were
then fully debriefed and thanked for their time, cooperation and
patience.
RESULTS
Knowledge acquisition
Overall numbers of correct responses to the 20 knowledge items
increased between the pre- and post-trial conditions (see Table 1).
A related t-test revealed that overall levels of correct responses
significantly increased between the pre- and post-trial conditions
(t [59]¼4.49, Po0.001). A multiple regression analysis showed
that being married was a significant predictor of overall knowledge
gain between the pre- and post-trial conditions (b¼0.31,
R
2¼0.10, Po0.05).
Correct responses for each of the five knowledge domains
increased between the pre- and post-trial conditions (see Table 1).
A two-factor repeated measures ANOVA revealed a significant
main effect of knowledge domain (F [3.5,206.6]¼15.67, Po0.001,
MSknowledge domain¼12.30, Greenhouse–Geisser correction ap-
plied) and a significant interaction effect between knowledge
domain and study condition (F [3.19,187.89]¼12.22, Po0.001,
MSinteraction¼12.91). A series of simple effect tests revealed that
the following knowledge domains increased significantly between
the pre- and post-trial conditions: cancer in general and prostate
anatomy (t [59]¼ 2.34, Po0.05), disease advancement (t
[59]¼ 2.92, Po0.01), aims and side effects of radiotherapy (t
[59]¼ 2.25, Po0.05) and hormone therapy (t [59]¼ 4.51,
Po0.001). Knowledge gain for aims and side effects of surgery
failed to reach significance.
Psychosocial functioning
Responses to the 20 psychosocial functioning items at pretrial were
subjected to a principle components analysis. A three-component
solution was extracted that explained 47% of the variance (see
Table 2). Each component possessed adequate factor loadings
(0.52–0.94) and internal reliability with Cronbach’s alpha values of
X0.68. The three components were subsequently named distress
(feelings of shock and fear), positive approach (optimism and a
fighting spirit) and nonacceptance (denial) that explained 25, 13
and 10% of the variance respectively. Distress was significantly
positively associated with both positive approach (r [61]¼0.32,
Po0.05) and nonacceptance (r [60]¼0.31, Po0.05) in both study
conditions. A related t-test revealed that distress decreased
significantly between the pre- and post-trial conditions
(t [58]¼2.35, Po0.05).
Treatment decision-making
In the pre- and post-trial study conditions, 68 and 71%
respectively of participants preferred an active or collaborative
role in treatment decisions. Wilcoxon tests revealed no significant
differences in treatment decision-making roles between the pre-
and post-trial study conditions; however, a significant shift in
preferences for a more active role in treatment decisions was
reported for (a) participants who attended the study session with
their spouse or partner (z [42]¼ 2.49, Po0.05) and (b)
participants who were married (z [47]¼ 1.98, Po0.05).
Information needs
The information needs reported by the study participants
were examined for common themes and coded into mutually
exclusive categories (see Table 3). A frequency analysis
revealed six categories of primary information needs at pretrial
with the following hierarchical structure: likelihood of a cure
(28%), treatment side effects (15%), coping strategies (13%),
diagnostic tests (12%), treatment duration (7%) and aetiology
(4%). In total, 19% stated that they had no information needs at
pretrial.
At post-trial, five categories of information needs displayed
at least a 40% decrease, with only aetiology displaying a
negligible increase. Approximately 66% of the participants
indicated that they required no further information needs
at post-trial. Seven categories were reported as the most
important knowledge acquired with the following hierarchical
structure: hereditary risks (30%), aetiology (24%), likelihood of a
cure (4%), disease advancement (4%), coping strategies (2%),
diagnostic tests (2%) and treatment side effects (2%). Approxi-
mately 33% could not decide upon the most important knowledge
they had acquired.
DISCUSSION
Consistent with previous research evaluating patient education
tools, patients in the current study reported significantly less
distress (Gregoire et al, 1997; Davison et al, 2003), more cancer-
related knowledge (Glajchen and Moul, 1996), and a desire for a
more active role in treatment decisions (if they attended the
session with their spouse/partner or were married) immediately
after browsing the MMP.
The current study also demonstrated that men expressed similar
patterns of psychosocial problems as women with cancer as they
reported anxiety, fear and shock (distress) and utilised both
positive (positive approach) and negative (nonacceptance) coping
strategies (Fallowfield et al, 1997; van Wersch et al, 1997a,b). The
association between distress and nonacceptance was also consis-
tent with previous research that found men with cancer are prone
to relying upon avoidance coping strategies in response to the
stress of a life-threatening disease such as cancer (Vingerhoets and
Van Heck, 1990). The reduction in distress is an important finding
given that less distressed patients are better able to make sense of
their experience with cancer and seek desired information (Leydon
et al, 2000).
Table 3 Information needs at pre- and post-trial and most important
knowledge acquired
Most
important
information
need
Most
important
information
still required
Most
important
knowledge
acquired
Pretrial Post-trial Post-trial
F% FF % FF % F
Likelihood of a cure 19 28 10 15 3 4
Treatment side effects 10 15 4 6 1 2
Coping strategies 9 13 4 6 1 2
Diagnostic tests 8 12 0 0 1 2
Treatment duration 5 7 1 2 0 0
Aetiology 3 4 4 6 16 24
Hereditary risks 0 0 0 0 20 30
Disease advancement 0 0 0 0 3 4
Cannot decide 13 19 44 66 22 33
Totals 67 100 67 100 67 100
Note: Percentages may not equal 100 due to rounding.
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research using the Control Preference Scale (CPS) that reported the
majority of men within 0–13 weeks of receiving their diagnosis
preferred a passive decision-making role (Davison et al, 1995).
However, more recent studies utilising the CPS are congruent with
the current study reporting that 68% (Davison and Degner, 1997),
75% (Wong et al, 2000) and as many as 93% (Davison et al, 2002)
of men recently diagnosed prefer either an active or collaborative
role in treatment decisions. This trend in the current study could
be attributed to the relatively low mean age of the study
participants (Davison et al, 2002), and/or spousal support that
served as a catalyst to learn and take part in shared decision-
making (Ptacek et al, 1999).
The MMP adequately fulfilled information needs for treatment
side effects, coping strategies, diagnostic tests and treatment
duration. The failure of the MMP to completely satisfy information
needs related to the likelihood of a cure and aetiology is probably
attributable to the state of medical knowledge and the lack of
prospective clinical trials of sufficient quality comparing one
treatment with another rather than shortcomings of the MMP.
Browsing the MMP developed a need to acquire information
other than those anticipated at pretrial and to reprioritise
information needs. However, the hierarchical structure of infor-
mation needs was inconsistent with previous research (Davison
et al, 1995, 2002). The discrepancies with previous research may be
due to using free-response questions, only requesting primary
information needs, and 19% of men in the pretrial condition
indicating they did not have any information needs, which
increased to 66% at post-trial.
Limitations
Despite these encouraging results, there are several methodological
issues that may have had a confounding influence upon the
outcome measures. The sampling method (selection by urologist)
employed to select participants may have produced an unrepre-
sentative sample as reasons for noninclusion were not recorded.
Other methodological issues that potentially reduce generalisa-
bility of the results include the failure to record the participants’
disease stage and functional status. Furthermore, given the
generally late onset of prostate cancer, the mean age (66years)
of the study participants was relatively young.
The psychosocial functioning scale utilised in the current study
needs to be further validated in future research, as only internal
reliability and internal validity was assessed. A research assistant
also supported the participants throughout the study session,
which may have impacted upon the participants’ level of distress.
Furthermore, the question of whether the level of support provided
is necessary in future applications of the MMP needs to be
investigated.
Suggested improvements to the MMP
The inclusion of a decision-aid to communicate quantitative
outcome information to patients could address the shortcomings
of the MMP in terms of fulfilling information needs. However, the
decision-aid used to present outcome data must be processed with
a high degree of accuracy by patients, otherwise it can influence
the perception of probability (Chatterton, 1999). According to
Feldman-Stewart et al (2000) a 10 10 matrix of shaded ovals is
the most efficacious format for presenting information on
probabilities to patients, although this must be explained with
support from clinicians.
Coping knowledge may be enhanced by amalgamating informa-
tion on positive coping strategies with other salient topics such as
likelihood of cure. To enable men to vicariously learn positive
coping strategies, streaming video of a real-patient (or trained
actor) describing the probability of a cure associated with each
disease stage could be followed by a description of how to develop
positive coping strategies to deal with treatment side effects.
An assessment of reading level required to comprehend
the information presented in the MMP needs to be conducted
to ensure understanding by all patients irrespective of
educational background. A self-test at the end of each topic
that provides feedback on performance (and delivering reassur-
ance and support in the case of poor performance) could also
enhance learning via the use of positive reinforcement (operant
conditioning). The inclusion of a search function would also
facilitate learning as patients could pinpoint salient information
needs more quickly and avoid the frustration of being unable to
locate desired information. Following a summative evaluation,
algorithms built into the MMP could suggest an appropriate
treatment modality based on a patient’s unique status (clinical
profile and preferences regarding both positive and negative
treatment outcomes).
Future research
The use of the MMP for prostate cancer patients at this stage of
evaluation cannot be recommended until prospective randomised
control trials to compare the utility of the MMP with good clinical
practice have been completed. In a summative evaluation,
important factors such as ‘usability’ may have influenced the
outcome measures in the current study. Usability refers to the ease
of use and acceptability of a product for particular types of user to
perform specific tasks in a given context, which is influenced by
cost, convenience, availability, prerequisite training and organisa-
tional issues (Bevan and McLeod, 1994). Therefore, a combination
of performance measures and assessments of user satisfaction is
required to determine the usability of the MMP in both clinical and
residential environments as a function of style and properties of
the interface (e.g. methods used to communicate between the user
and computer), dialogue structure, functionality (e.g. browsing
content), efficiency (e.g. navigation structure), reliability (e.g. fault
tolerance), user characteristics (e.g. age) including the combina-
tion of attributes that provide the greatest level of satisfaction for
the majority of users. Particular attention should be given to
obtaining information from patients who dislike or feel uncom-
fortable using computers. Ergonomic factors such as postural
demands may also be related to perceived ease of use, especially in
elderly men, and deserve consideration in future applications of
this MMP.
High usability of the MMP is essential if the MMP is to be used
in patients’ homes or accessed via the WWW, to ensure that the
MMP can successfully compete with the perennial increase in the
number of cancer-related Web sites on the Internet. In particular,
it must be established if the MMP confers benefits over time in
terms of outcomes assessed in the current study, including
satisfaction with care, quality of life and ultimately survival.
Furthermore, future work should be conducted to determine if the
MMP can fulfil post-treatment information needs and those of
partner-caregivers who are reported to have information needs
equivalent to those of patients (Davison et al, 2002).
CONCLUSION
The incidence of prostate cancer is expected to increase in
developed countries due to ageing populations, increased use of
PSA screening and declines in other major causes of mortality.
This will result in concomitant cost increases to health care
providers and it is unlikely that the slow and expensive process of
training biomedical practitioners occupying the central role in
health care will meet the increased demand for their ‘expert
knowledge’ (Weed, 1997). However, empowered with sufficient
knowledge patients can make informed decisions about their
treatment in collaboration with clinicians without an investment of
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unlikely to replace the ‘human touch’ associated with traditional
doctor–patient interactions, although, in the present climate of
health care reform, which is geared toward the cost-effective
delivery of quality services, MMPs will become increasingly
commonplace tools for patient education if they are demonstrated
to be more effective than good clinical practice.
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